Remy Blaire is joined by Ryan Pace, Co-Founder and CEO of Involio. Pace discusses the platforms emergence as a leader in providing opportunities for users/traders to monetize their investment strategies. The company has accrued 130k users with zero marketing spend and continues to innovate in the intersection of content creation and investment strategy.
Insurance affordability with Larry Lawrence
Larry Lawrence, Vice President and Global Head of Sustainable Finance Data at ICE, joins Jeff Gitterman to discuss New York Climate Week. They also discuss insurance affordability, the growing risk to home prices, and mortgage-backed securities.
Apple Intelligence, Blockchain ESG, Bitcoin Nears Record, Robinhood Betting
Apple releases a new AI features to to propel sales of iPhone. Blockchain is helping companies report ESG. Bitcoin surged above $71,000 as shorts were liquidated and Robinhood now allows users to bet on the U.S. presidential election. Jane King has the latest from the Nasdaq.
How Nvidia is powering innovation across financial institutions with Malcolm deMayo
Malcolm deMayo, Global Vice President of Financial Services at Nvidia, dives into the company’s influence on financial institutions and how generative AI is creating innovation in digital finance. Remy Blaire and deMayo discuss Nvidia’s role in advancing AI capabilities within the financial sector, as well as how Gen AI is transforming digital financial services through enhanced data analysis. deMayo also touches on how Nvidia utilizes strategic partnerships to further engage the financial industry.
Money 20/20’s key trends and the future of fintech with David Wachsman
David Wachsman highlights the key trends and innovations showcased at Money 20/20, as well as his insights into the potential impact of the upcoming election on the fintech industry. He explores how trends like digital payments, AI in finance, and regulatory shifts are shaping fintech and what the election’s outcome could mean for the sector’s growth. Wachsman also touches on what to expect from the Federal Reserve’s November meeting.
The future of financial technology, regulations, and legislation in the US with Cleve Mesidor, Executive Director of The Blockchain Foundation
Cleve Mesidor, Executive Director of The Blockchain Foundation, unpacks the future of finance in the U.S. by exploring the evolving landscape of regulations and legislation. Mesidor discusses how emerging policies are shaping digital assets, what investors and businesses should anticipate, and the role of blockchain in driving financial transformation.
Anticipating the last full trading week before the election with Peter Tuchman
Peter Tuchman and J.D. Durkin anticipate the trading week ahead before next week’s presidential election. The pair touch on NYSE’s announcement to increase trading hours as well as performance from Mag-7 stocks.
Guardian Pharmacies’ end-to-end solutions for safer medication management with Fred Burke
Fred Burke of Guardian Pharmacy Services discusses how the company provides end-to-end medication management solutions designed to improve patient care and streamline healthcare processes. Burke highlights Guardian’s innovative approach to ensuring medication accuracy, enhancing patient safety, and supporting healthcare providers.
How Global Policy House aims to be a leader in digital transformation, regulations, and ethics in AI with Michelle Chivunga
Michelle Chivunga, founder of Global Policy House, outlines her vision for the organization’s role in leading digital transformation, shaping regulations, and setting ethical standards in AI. Chivunga discusses the importance of responsible AI development, the need for regulatory frameworks, and how Global Policy House is working to set the foundation for a trustworthy digital future. Additionally, Chivunga discusses the growing institutional adoption of crypto and other digital assets.
How Kairos is innovating cancer treatment by targeting cancer drug resistance with John Yu
Remy Blaire sits down with John Yu, CEO and Chairman of Kairos Pharmaceutics, to discuss how the company is developing groundbreaking therapeutics aimed at reversing cancer drug resistance. Yu explains the science behind Kairos’s innovative approach, the potential impact on cancer treatment, and how these advancements could improve patient outcomes.